Contact Lenses and Infectious Keratitis: From a Case-Control Study to a Computation of the Risk for Wearers.


Journal

Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186

Informations de publication

Date de publication:
Jun 2020
Historique:
pubmed: 29 1 2020
medline: 26 3 2021
entrez: 29 1 2020
Statut: ppublish

Résumé

Contact lens (CL)-related microbial keratitis (MK) has major public health implications, with about 300 million wearers worldwide, and certain potentially modifiable risk factors. This study aimed to identify the risk factors of CL-related MK. A multicenter case-control study was conducted between 2014 and 2017. Cases presenting with CL-related MK were submitted to an anonymous 52-item questionnaire, which was also completed by healthy controls. Univariate followed by multivariate logistic regression analysis was performed. Risk factors for CL-related MK were given as odds ratio (OR) with 95% confidence interval and P-value. The study included a total of 2267 patients (1198 cases and 1069 controls). The MK risk factors for the daily disposable lenses group were exceeding the lens renewal period (OR = 9.16, P = 0.008) and occasionally wearing CL when sleeping (OR = 15.83, P = 0.035). The most important risk factors in the nondaily disposable lenses group were lens cleaning solution distributed by eye care brands (OR = 3.50, P < 0.001) and failure to renew lens cases (OR = 3.39, P = 0.001). Statistically and clinically significant variables were used to establish the MK risk equation for CL wearers, allowing an individual calculation of the risk of MK under lenses. The MK risk equation is a valuable tool for educating patients about the risks associated with wearing CL. It allows the patient to be informed about their overall risk of infection while detailing the precipitating elements of the infectious risk with the aim of modifying risk behavior.

Identifiants

pubmed: 31990844
doi: 10.1097/ICO.0000000000002248
pii: 00003226-202006000-00018
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

769-774

Références

Nichols JJ. Contact Lenses 2017: Continuing upward trends in daily disposable prescribing and other key segments maintained a healthy industry. Contact Lens Spectrum. 2018. Available at: https://www.clspectrum.com/issues/2018/january-2018/contact-lenses-2017. Accessed October 10, 2018.
Beeler M. EUROMCONTACT Releases 2017 Market Data. Available at: https://www.efclin.com/?p=2922. European Federation of the Contact Lens and IOL Industries. 2018. Accessed October 10, 2018.
Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis predisposing factors and morbidity. Ophthalmology. 2006;113:109–116.
Schein OD, Poggio EC. Ulcerative keratitis in contact lens wearers. Incidence and risk factors. Cornea. 1990;9:55–63.
Stapleton F, Keay L, Edwards K, et al. The incidence of contact lens-related microbial keratitis in Australia. Ophthalmology. 2008;115:1655–1662.
Stapleton F, Naduvilath T, Keay L, et al. Risk factors and causative organisms in microbial keratitis in daily disposable contact lens wear. PLoS One. 2017;12:e0181343.
Collier SA, Gronostaj MP, MacGurn AK, et al. Estimated burden of keratitis—United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63:1027–1030.
Keay L, Edwards K, Dart J, et al. Grading contact lens-related microbial keratitis: relevance to disease burden. Optom Vis Sci. 2008;85:531–537.
Sauer A, Meyer N, Bourcier T. French study group for contact lens–related microbial keratitis. Risk factors for contact lens-related microbial keratitis: a case-control multicenter study. Eye Contact Lens. 2016;42:158–162.
Becmeur PH, Abry F, Bourcier T, et al. Risk factors for contact lens-related microbial keratitis: a multicenter case-control study. J Fr Ophtalmol. 2017;40:224–231.
Radford CF, Minassian D, Dart JK, et al. Risk factors for nonulcerative contact lens complications in an ophthalmic accident and emergency department: a case-control study. Ophthalmology. 2009;116:385–392.
Dart JK, Radford CF, Minassian D, et al. Risk factors for microbial keratitis with contemporary contact lenses: a case-control study. Ophthalmology. 2008;115:1647–1654.
Dart JK, Stapleton F, Minassian D. Contact lenses and other risk factors in microbial keratitis. Lancet. 1991;338:650–653.
Stapleton F, Carnt N. Contact lens-related microbial keratitis: how have epidemiology and genetics helped us with pathogenesis and prophylaxis. Eye (Lond). 2012;26:185–193.
Schein OD, Glynn RJ, Poggio EC, et al. The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. A case-control study. Microbial Keratitis Study Group. N Engl J Med. 1989;321:773–778.
Official Journal. The conditions for the issuance of corrective glasses or corrective contact lenses and the rules of practice of the profession of optician. Available at: https://www.legifrance.gouv.fr/eli/decret/2016/10/12/AFSH1624105D/jo/texte. Accessed October 10, 2018.
Donshik PC, Ehlers WH, Anderson LD, et al. Strategies to better engage, educate, and empower patient compliance and safe lens wear: compliance: what we know, what we do not know, and what we need to know. Eye Contact Lens. 2007;33:430–433.
Gyawali R, Nestha Mohamed F, Bist J, et al. Compliance and hygiene behaviour among soft contact lens wearers in the Maldives. Clin Exp Optom. 2014;97:43–47.
Kuzman T, Kutija MB, Masnec S, et al. Compliance among soft contact lens wearers. Coll Antropol. 2014;38:1217–1221.
Efron N, Morgan PB. Rethinking contact lens aftercare. Clin Exp Optom. 2017;100:411–431.
Morjaria R, Crombie R, Patel A. Retained contact lenses. BMJ. 2017;358:j278.

Auteurs

Arnaud Sauer (A)

Ophtalmologie, Centre Hospitalier Universitaire (CHU), Université de Strasbourg, Nouvel Hôpital Civil, 1 Place de l'Hôpital, Strasbourg, France.

Mathieu Greth (M)

Ophtalmologie, Centre Hospitalier Universitaire (CHU), Université de Strasbourg, Nouvel Hôpital Civil, 1 Place de l'Hôpital, Strasbourg, France.

Jonathan Letsch (J)

Ophtalmologie, Centre Hospitalier Universitaire (CHU), Université de Strasbourg, Nouvel Hôpital Civil, 1 Place de l'Hôpital, Strasbourg, France.

Pierre-Henri Becmeur (PH)

Ophtalmologie, Centre Hospitalier Universitaire (CHU), Université de Strasbourg, Nouvel Hôpital Civil, 1 Place de l'Hôpital, Strasbourg, France.

Vincent Borderie (V)

Ophtalmologie, Centre Hospitalier Universitaire des XV-XX, Paris, France.

Vincent Daien (V)

Ophtalmologie, Centre Hospitalier Universitaire de Montpellier, France.

Alain Bron (A)

Ophtalmologie, Centre Hospitalier Universitaire de Dijon, France.

Catherine Creuzot-Garcher (C)

Ophtalmologie, Centre Hospitalier Universitaire de Dijon, France.

Laurent Kodjikian (L)

Ophtalmologie, Centre Hospitalier Universitaire de Lyon, France.

Carole Burillon (C)

Ophtalmologie, Centre Hospitalier Universitaire de Lyon, France.

Pierre-Yves Robert (PY)

Ophtalmologie, Centre Hospitalier Universitaire de Limoges, France.

Frédéric Mouriaux (F)

Ophtalmologie, Centre Hospitalier Universitaire de Rennes, France.

Marc Muraine (M)

Ophtalmologie, Centre Hospitalier Universitaire de Rouen, France.

Julie Gueudry (J)

Ophtalmologie, Centre Hospitalier Universitaire de Rouen, France.

Francois Malecaze (F)

Ophtalmologie, Centre Hospitalier Universitaire de Toulouse, France.

Béatrice Cochener (B)

Ophtalmologie, Centre Hospitalier Universitaire de Brest, France.

Christophe Chiquet (C)

Ophtalmologie, Centre Hospitalier Universitaire de Grenoble, France; and.

Marc Labetoulle (M)

Ophtalmologie, Centre Hospitalier Universitaire de Paris, Kremlin-Bicêtre, Paris, France.

Tristan Bourcier (T)

Ophtalmologie, Centre Hospitalier Universitaire (CHU), Université de Strasbourg, Nouvel Hôpital Civil, 1 Place de l'Hôpital, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH